139 related articles for article (PubMed ID: 25923658)
1. Acute phase IL-10 plasma concentration associates with the high risk sources of cardiogenic stroke.
Arponen O; Muuronen A; Taina M; Sipola P; Hedman M; Jäkälä P; Vanninen R; Pulkki K; Mustonen P
PLoS One; 2015; 10(4):e0120910. PubMed ID: 25923658
[TBL] [Abstract][Full Text] [Related]
2. Evaluating patients with acute ischemic stroke with special reference to newly developed atrial fibrillation in cerebral embolism.
Tagawa M; Takeuchi S; Chinushi M; Saeki M; Taniguchi Y; Nakamura Y; Ohno H; Kitazawa K; Aizawa Y
Pacing Clin Electrophysiol; 2007 Sep; 30(9):1121-8. PubMed ID: 17725756
[TBL] [Abstract][Full Text] [Related]
3. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers.
Montaner J; Perea-Gainza M; Delgado P; Ribó M; Chacón P; Rosell A; Quintana M; Palacios ME; Molina CA; Alvarez-Sabín J
Stroke; 2008 Aug; 39(8):2280-7. PubMed ID: 18535284
[TBL] [Abstract][Full Text] [Related]
4. Is serum total bilirubin useful to differentiate cardioembolic stroke from other stroke subtypes?
Lin SP; Lin PY; Jiang HL; Long YM; Chen XH
Neurol Res; 2015 Aug; 37(8):727-31. PubMed ID: 25891436
[TBL] [Abstract][Full Text] [Related]
5. Validation of the use of B-type natriuretic peptide point-of-care test platform in preliminary recognition of cardioembolic stroke patients in the ED.
Wu Z; Zhao M; He M; Zeng H; Tan F; Li K; Chen S; Han Q; Wang Q
Am J Emerg Med; 2015 Apr; 33(4):521-6. PubMed ID: 25669874
[TBL] [Abstract][Full Text] [Related]
6. Lp(a) lipoprotein and plasminogen activity in patients with different etiology of ischemic stroke.
Petersen NH; Schmied AB; Zeller JA; Plendl H; Deuschl G; Zunker P
Cerebrovasc Dis; 2007; 23(2-3):188-93. PubMed ID: 17143002
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a), other lipoproteins and hemostatic profiles in patients with ischemic stroke: the relation to cardiogenic embolism.
Dahl T; Kontny F; Slagsvold CE; Christophersen B; Abildgaard U; Odegaard OR; Morkrid L; Dale J
Cerebrovasc Dis; 2000; 10(2):110-7. PubMed ID: 10686449
[TBL] [Abstract][Full Text] [Related]
8. Association of serum uric acid and cardioembolic stroke in patients with acute ischemic stroke.
Yang XL; Kim Y; Kim TJ; Jung S; Kim CK; Lee SH
J Neurol Sci; 2016 Nov; 370():57-62. PubMed ID: 27772788
[TBL] [Abstract][Full Text] [Related]
9. Brain natriuretic peptide in acute ischemic stroke.
Maruyama K; Shiga T; Iijima M; Moriya S; Mizuno S; Toi S; Arai K; Ashihara K; Abe K; Uchiyama S
J Stroke Cerebrovasc Dis; 2014; 23(5):967-72. PubMed ID: 24119617
[TBL] [Abstract][Full Text] [Related]
10. Plasma natriuretic peptides and incidence of subtypes of ischemic stroke.
Berntsson J; Zia E; Borné Y; Melander O; Hedblad B; Engström G
Cerebrovasc Dis; 2014; 37(6):444-50. PubMed ID: 25060145
[TBL] [Abstract][Full Text] [Related]
11. Association of plasma brain natriuretic peptide levels in acute ischemic stroke subtypes and outcome.
Chaudhuri JR; Sharma VK; Mridula KR; Balaraju B; Bandaru VC
J Stroke Cerebrovasc Dis; 2015 Feb; 24(2):485-91. PubMed ID: 25524015
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
[TBL] [Abstract][Full Text] [Related]
13. Free fatty acid as an outcome predictor of atrial fibrillation-associated stroke.
Choi JY; Jung JM; Kwon DY; Park MH; Kim JH; Oh K; Koh SB; Seo WK
Ann Neurol; 2016 Feb; 79(2):317-25. PubMed ID: 26606741
[TBL] [Abstract][Full Text] [Related]
14. Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome.
Petzold A; Michel P; Stock M; Schluep M
J Stroke Cerebrovasc Dis; 2008; 17(4):196-203. PubMed ID: 18589339
[TBL] [Abstract][Full Text] [Related]
15. Free fatty acid as a determinant of ischemic lesion volume in nonarterial-origin embolic stroke.
Chung JW; Seo WK; Kim GM; Chung CS; Lee KH; Bang OY
J Neurol Sci; 2017 Nov; 382():116-121. PubMed ID: 29111002
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study.
Shin DH; Lee PH; Bang OY
Arch Neurol; 2005 Aug; 62(8):1232-7. PubMed ID: 16087764
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 may protect against progressing injury during the acute phase of ischemic stroke.
Protti GG; Gagliardi RJ; Forte WC; Sprovieri SR
Arq Neuropsiquiatr; 2013 Nov; 71(11):846-51. PubMed ID: 24394869
[TBL] [Abstract][Full Text] [Related]
18. Cardiac MRI improves identification of etiology of acute ischemic stroke.
Baher A; Mowla A; Kodali S; Polsani VR; Nabi F; Nagueh SF; Volpi JJ; Shah DJ
Cerebrovasc Dis; 2014; 37(4):277-84. PubMed ID: 24819735
[TBL] [Abstract][Full Text] [Related]
19. Expression of IL-6 activity in patients with acute ischemic stroke.
Cojocaru IM; Cojocaru M; Tănăsescu R; Iliescu I; Dumitrescu L; Silosi I
Rom J Intern Med; 2009; 47(4):393-6. PubMed ID: 21179922
[TBL] [Abstract][Full Text] [Related]
20. [Role of homocysteine in the acute phase of stroke].
Ribo M; Montaner J; Monasterio J; Molina C; Arenillas J; Chacon P; Alvarez-Sabin J
Neurologia; 2004; 19(1):10-4. PubMed ID: 14762728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
